Mylan’s EpiPen continues making news, prompting patients to compare drug prices. They look at the prices in Canada, our closest neighbor, and they wonder why the prices here are two to three times higher for the same product. It is both dramatic and unsettling. The pharmaceutical industry answer is “it’s complicated.” Yes, it is complicated. For example, we’ve heard the argument about how Canada is single payer system and the…
The post Drug Pricing Need Not Be This Hard appeared first on Whitelaw Compliance Group, LLC.